ABBV
AbbVie Inc.
Latest News for ABBV
U.S. stocks ended the week lower as pressure from rates and commodities weighed on risk appetite. The Dow Jones Industrial Average (DJIA) fell 0.36......
The Trump administration has announced the names of 15 drugs targeted for Medicare price negotiations for 2028. The new list of branded medications......
Abbvie ($ABBV) announced an update on their ongoing clinical study. Study Overview: AbbVie is running an early-stage trial called “A Phase 1 Study ......
UnitedHealth Group ($UNH) is set to report its Q4 earnings on January 27. Analysts expect revenue of about $113.77 billion, up 12.9% year‑over‑year......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbbVie (ABBV – Research Report) and Acadia Healthc......
Bernstein analyst Courtney Breen maintained a Hold rating on AbbVie yesterday and set a price target of $225.00. Breen covers the Healthcare sector......
Abbvie ($ABBV) announced an update on their ongoing clinical study. Study Overview: AbbVie is running a phase 1, first-in-human trial (NCT07241039)......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Jazz Pharmaceuticals (JAZZ – Research Report) and AbbVie (ABBV – ......
Abbvie ($ABBV) announced an update on their ongoing clinical study. Study Overview: AbbVie is running an observational study titled “Observational ......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AbbVie (ABBV – Research Report) and Glaukos (GKOS – ......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 21 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABBV | $225.64 | +1.2% | 5.39M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |